All Stories

  1. Methicillin-Resistant Staphylococcus aureus: Risk for General Infection and Endocarditis Among Athletes

    Article • Antibiotics, June 2020, MDPI AG

    Fabio Fimiani

  2. Improving Adherence to Ticagrelor in Patients After Acute Coronary Syndrome: Results from the PROGRESS Trial

    Article • Current Vascular Pharmacology, April 2020, Bentham Science Publishers

    Dr Marco Di Maio, Fabio Fimiani

  3. Pleiotropic effects of PCSK9

    Article • BioFactors, January 2020, Wiley

    Arturo Cesaro, Fabio Fimiani

  4. Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)

    Article • The American Journal of Cardiology, December 2019, Elsevier

    Fabio Fimiani

  5. ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial

    Article • Journal of Electrocardiology, November 2019, Elsevier

    Fabio Fimiani

  6. Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease

    Article • Internal and Emergency Medicine, March 2019, Springer Science + Business Media

    Fabio Fimiani

  7. Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk

    Article • European Journal of Preventive Cardiology, March 2019, SAGE Publications

    Fabio Fimiani

  8. Laboratory medicine: health evaluation in elite athletes

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2019, De Gruyter

    Fabio Fimiani

  9. Lomitapide in homozygous familial hypercholesterolemia

    Article • Journal of Cardiovascular Medicine, March 2018, Wolters Kluwer Health

    Fabio Fimiani

  10. Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients

    Article • Journal of Cardiovascular Medicine, February 2018, Wolters Kluwer Health

    Fabio Fimiani

  11. Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target

    Article • Current Vascular Pharmacology, August 2017, Bentham Science Publishers

    Fabio Fimiani

  12. Von Willebrand Factor as a Novel Player in Valvular Heart Disease: From Bench to Valve Replacement

    Article • Angiology, May 2017, SAGE Publications

    Fabio Fimiani

  13. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Fabio Fimiani

  14. From Femoral to Radial Approach in Coronary Intervention

    Article • Angiology, July 2016, SAGE Publications

    Fabio Fimiani

  15. Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms?

    Article • International Journal of Cardiology, November 2015, Elsevier

    Fabio Fimiani

  16. Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target

    Article • Current Atherosclerosis Reports, July 2014, Springer Science + Business Media

    Fabio Fimiani